Research ArticleCancer

A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions

See allHide authors and affiliations

Science Translational Medicine  11 Jan 2017:
Vol. 9, Issue 372, eaag2611
DOI: 10.1126/scitranslmed.aag2611

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article